Companies: 10,795·Total market cap: $144.5T

Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd.

GLMDNASDAQHealthcare● Active

$0.52

$-0.17(-24.84%)

Market Cap$2866185

P/E Ratio—

52W High$2.34

52W Low$0.411

Avg Volume3.0M

Open$0.59

Beta0.71

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Galmed Pharmaceuticals Ltd.（GLMD）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · GLMD · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-2.33Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding4.3MShares outstanding history

Next EarningsJul 30, 2026Est.Earnings history

探索 Galmed Pharmaceuticals Ltd. 数据

分析师预测$— · Buy

股息不分红

盈利EPS $-2.39+70.42%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$10.3M▼ 37.14% YoY

202320242025

FY 2025EPS$-2.39▲ +70.42% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$10.3MEPS: $-2.33View income statement →

分析师评级与目标价

Buy16 位分析师

Strong Buy

0

Buy

10

Hold

6

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$0.52Current

$—Avg Target

$—High

合计: 16 · 买入占比: 62.5%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Galmed Pharmaceuticals Ltd.

$0.52-24.84%$2.9M #2

Biodexa Pharmaceuticals Plc

$3.37+1.19%$56,534.22 #3

$1.67+5.94%$12.6M #4

Chemomab Therapeutics Ltd.

$1.82+2.82%$11.2M #5

PMGC Holdings Inc.

$1.60+0.97%$3.1M #6

InMed Pharmaceuticals Inc.

$1.51-3.80%$2.7M

股票表现

1D-34.21%

1W-34.12%

1M-25.06%

3M-30.62%

YTD-38.99%

1Y-71.73%

5Y-99.93%

关于 Galmed Pharmaceuticals Ltd.

CEOAllen Baharaff

IPO DateMar 13, 2014

Employees3

CountryIL

Websitegalmedpharma.com

Galmed Pharmaceuticals Ltd. a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is…

Biotechnology HealthcareNASDAQIL

关于股票概览与关键数据

Galmed Pharmaceuticals Ltd.（GLMD）是 Biotechnology 行业的 Healthcare 类公司，于 Mar 13, 2014 在 NASDAQ 上市。截至最近交易日，GLMD 股价为 $0.52，市值约为 $2.5M。过去12个月累计回报 -71.73%，年初至今回报 -38.99%。

根据 16 位华尔街分析师，Galmed Pharmaceuticals Ltd. 股票共识评级为Buy，12个月平均目标价为 $—。2025 财年 Galmed Pharmaceuticals Ltd. 营收 —，净利润 -$10.3M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Galmed Pharmaceuticals Ltd.（GLMD）股价为 $0.52，在 NASDAQ 上市，52周区间为 $0.41 – $2.34。

GLMD 最新股价GLMD quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议